Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Moderna, Inc. (MRNA)
Sector: Healthcare; Industry: Biotechnology

Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. Moderna, Inc. also has a collaboration with Lonza Ltd. for the manufacture of mRNA-1273, a COVID-19 vaccine. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2020-02-14 SAGAN PAUL Director Buy 52,631 $19.00 $999,989 No
2020-02-14 Bancel Stephane Chief Executive Officer Sell 11,046 $19.02 $210,095 No
2020-02-13 Hoge Stephen President Sell 10,000 $19.34 $193,350 No
2020-02-07 Kim Lorence H. Chief Financial Officer Sell 33,295 $23.06 $767,783 No
2020-02-10 Bancel Stephane Chief Executive Officer Sell 33,134 $22.65 $750,582 No
2020-02-03 Bancel Stephane Chief Executive Officer Sell 4,876 $20.66 $100,738 No
2020-01-31 Bancel Stephane Chief Executive Officer Sell 11,046 $20.43 $225,633 No
2020-01-28 Kim Lorence H. Chief Financial Officer Sell 24,705 $23.02 $568,786 No
2020-01-24 Hoge Stephen President Sell 10,000 $21.61 $216,073 No
2020-01-24 Bancel Stephane Chief Executive Officer Sell 11,046 $21.22 $234,396 No
2020-01-22 Kim Lorence H. Chief Financial Officer Sell 2,000 $23.04 $46,080 No
2020-01-22 Bancel Stephane Chief Executive Officer Sell 15,398 $23.00 $354,154 No
2020-01-21 Bancel Stephane Chief Executive Officer Sell 4,850 $20.79 $100,832 No
2020-01-17 Bancel Stephane Chief Executive Officer Sell 11,046 $20.96 $231,524 No
2020-01-13 Hoge Stephen President Sell 10,000 $19.14 $191,400 No
2020-01-10 Bancel Stephane Chief Executive Officer Sell 16,482 $20.24 $333,582 No
2020-01-14 KANIA EDWIN M JR 10%-Owner Sell 475,000 $20.26 $9,623,813 No
2020-01-03 Bancel Stephane Chief Executive Officer Sell 16,160 $19.21 $310,397 No
2019-12-27 Bancel Stephane Chief Executive Officer Sell 11,046 $19.53 $215,728 No
2019-12-20 Bancel Stephane Chief Executive Officer Sell 11,046 $19.69 $217,496 No
2019-12-12 Zaks Tal Zvi Chief Medical Officer Sell 100,000 $18.54 $1,854,000 No
2019-12-13 Bancel Stephane Chief Executive Officer Sell 11,046 $18.53 $204,682 No
2019-12-10 KANIA EDWIN M JR 10%-Owner Sell 100,000 $18.81 $1,880,840 No
2019-12-11 Flagship Ventures Fund IV General Partner LLC 10%-Owner, Director Sell 435,855 $18.81 $8,196,936 No
2019-12-06 Kim Lorence H. Chief Financial Officer Sell 238,532 $20.00 $4,770,190 Yes
2019-12-06 Bancel Stephane Chief Executive Officer Sell 11,046 $20.01 $221,081 No
2019-11-29 Bancel Stephane Chief Executive Officer Sell 11,046 $20.54 $226,885 No
2019-11-22 Bancel Stephane Chief Executive Officer Sell 11,046 $20.48 $226,222 No
2019-11-20 HUTT PETER BARTON Director Sell 200,000 $20.18 $4,036,000 Yes
2019-11-15 Bancel Stephane Chief Executive Officer Sell 11,046 $19.03 $210,216 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

Mohawk Group Holdings, Inc. (MWK) - Multiple insiders bought MWK in June around $5, stock moved sideways for a month then made a 60% jump in 10 days. Patience is the key.